A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies

Clinical trial NCT05753722 · RECRUITING

Trial details

NCT number: NCT05753722
Sponsor: Incendia Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced or Metastatic Solid Tumors Non Small Cell Lung Cancer NSCLC

Start date: 2023-03-03
Primary completion: 2027-09-30
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.